Stem Cells
Therapies
Stem Cells Therapies
The purpose of banking stem cells is to apply them in the therapy. For the first time cord blood was used in 1988 and since then according to publicly available statistics it has been used over 85 000 times worldwide (including statistics of China).
FamiCord Group stores over 1,000,000 samples of cells of different types and has supplied stem cells for application in clinic for more than 7000 patients. We supply stem cells for standard transplantations (cord blood , bone marrow and mobilized peripheral blood) and cellular therapies. On top of that we provide cell based products in GMP standard for clinical trials.
Stem cells manufactured in our premises helped patients with various diseases and therapeutic areas, including haematological, neurological, ophthalmological, orthopaedical, dermatological disorders.
Check the full list of patients who received stem cell therapy derived from FamiCord labs.
List last update: 06.2026
List of patients who received stem cells from FamiCord Group laboratories
| Lp. | Source | Source type | Diagnosis | Medical field | Year of application | Therapy | Country | Age of recipient |
|---|---|---|---|---|---|---|---|---|
| 8401 | Apheresis | Autologous | Neuroblastoma | Hematology | 2013 | Standard Therapy | Germany | 1 |
| 8402 | Apheresis | Allogeneic | No Data | Hematology | 2013 | Standard Therapy | Germany | 51 |
| 8403 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2013 | Standard Therapy | Germany | 60 |
| 8404 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2013 | Standard Therapy | Germany | 60 |
| 8405 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2013 | Standard Therapy | Germany | 60 |
| 8406 | Apheresis | Autologous | Non-Hodgkin-Lymphoma-Relapse | Hematology | 2013 | Standard Therapy | Germany | 68 |
| 8407 | Apheresis | Autologous | Non-Hodgkin-Lymphoma-Relapse | Hematology | 2013 | Standard Therapy | Germany | 73 |
| 8408 | Apheresis | Autologous | Plasmacytoma | Hematology | 2013 | Standard Therapy | Germany | 62 |
| 8409 | Apheresis | Allogeneic | Primary Central Nervous System Lymphoma | Hematology | 2013 | Standard Therapy | Germany | 52 |
| 8410 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2013 | Standard Therapy | Germany | 43 |
| 8411 | Apheresis | Allogeneic | Primary Myelofibrosis, Second Acute Myeloid Leukemia | Hematology | 2013 | Standard Therapy | Germany | 60 |
| 8412 | Apheresis | Allogeneic | Primary Osteomyelofibrosis | Hematology | 2013 | Standard Therapy | Germany | 59 |
| 8413 | Apheresis | Allogeneic | T-Cell Acute Myeloid Leukemia | Hematology | 2013 | Standard Therapy | Germany | 61 |
| 8414 | Apheresis | Allogeneic | T-Cell Non-Hodgkin Lymphoma | Hematology | 2013 | Standard Therapy | Germany | 45 |
| 8415 | Apheresis | Autologous | Teratocarcinoma | Hematology | 2013 | Standard Therapy | Germany | 49 |
| 8416 | Apheresis | Autologous | Testicular Cancer Relapse | Hematology | 2013 | Standard Therapy | Germany | 27 |
| 8417 | Cord Tissue | Allogeneic – Unrelated | Acute Graft Versus Host Disease | Hematology | 2012 | Experimental Therapy | Poland | 19 |
| 8418 | Cord Tissue | Allogeneic – Unrelated | Acute Graft Versus Host Disease | Hematology | 2012 | Experimental Therapy | Poland | 7 |
| 8419 | Cord Tissue | Allogeneic – Unrelated | Acute Graft Versus Host Disease | Hematology | 2012 | Experimental Therapy | Poland | 4 |
| 8420 | Cord Blood | Allogeneic – Related | Acute Lymphoblastic Leukemia | Hematology | 2012 | Standard Therapy | Germany | 2 |
| 8421 | Cord Blood | Allogeneic – Related | Beta Thalassemia | Hematology | 2012 | Standard Therapy | Germany | 14 |
| 8422 | Cord Blood | Autologous | Brain Damage | Neurology | 2012 | Experimental Therapy | Germany | 3 |
| 8423 | Cord Blood | Autologous | Cerebral Palsy | Neurology | 2012 | Experimental Therapy | Portugal | 3 |
| 8424 | Cord Blood | Allogeneic – Related | Myelodysplastic Syndrome | Hematology | 2012 | Standard Therapy | Hungary | 3 |
| 8425 | Cord Blood | Allogeneic – Related | T-Cell Acute Lymphoblastic Leukemia | Hematology | 2012 | Standard Therapy | Turkey | 4 |
| 8426 | Cord Blood | Allogeneic – Related | Thalassemia Major | Hematology | 2012 | Standard Therapy | Turkey | 6 |
| 8427 | Cord Blood | Allogeneic – Related | Thalassemia Major, Acute Lymphoblastic Leukemia | Hematology | 2012 | Standard Therapy | Turkey | 3 |
| 8428 | Cord Blood | Autologous | Typ-1-Diabetes | Endocrinology | 2012 | Experimental Therapy | Germany | 5 |
| 8429 | Bone Marrow | Autologous | Ischemic Myopathy | Hematology | 2012 | Standard Therapy | Germany | 64 |
| 8430 | Bone Marrow | Autologous | Ischemic Myopathy | Hematology | 2012 | Standard Therapy | Germany | 75 |
| 8431 | Bone Marrow | Autologous | Ischemic Myopathy | Hematology | 2012 | Standard Therapy | Germany | 55 |
| 8432 | Bone Marrow | Autologous | Ischemic Myopathy | Hematology | 2012 | Standard Therapy | Germany | 56 |
| 8433 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome Refractory Anemia With Blast Excess | Hematology | 2012 | Standard Therapy | Germany | 70 |
| 8434 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2012 | Standard Therapy | Germany | 18 |
| 8435 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2012 | Standard Therapy | Germany | 42 |
| 8436 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2012 | Standard Therapy | Germany | 43 |
| 8437 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2012 | Standard Therapy | Germany | 60 |
| 8438 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2012 | Standard Therapy | Germany | 39 |
| 8439 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2012 | Standard Therapy | Germany | 62 |
| 8440 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2012 | Standard Therapy | Germany | 55 |
| 8441 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2012 | Standard Therapy | Germany | 17 |
| 8442 | Apheresis | Allogeneic | Acute Myeloid Leukemia – Relapse | Hematology | 2012 | Standard Therapy | Germany | 48 |
| 8443 | Apheresis | Allogeneic | Acute Myeloid Leukemia – Relapse | Hematology | 2012 | Standard Therapy | Germany | 46 |
| 8444 | Apheresis | Allogeneic | Acute Myeloid Leukemia – Relapse | Hematology | 2012 | Standard Therapy | Germany | 68 |
| 8445 | Apheresis | Allogeneic | Acute Myeloid Leukemia (High Risk) | Hematology | 2012 | Standard Therapy | Germany | 57 |
| 8446 | Apheresis | Allogeneic | B-Cell Acute Lymphoblastic Leukemia | Hematology | 2012 | Standard Therapy | Germany | 47 |
| 8447 | Apheresis | Allogeneic | B-Cell Acute Lymphoblastic Leukemia | Hematology | 2012 | Standard Therapy | Germany | 43 |
| 8448 | Apheresis | Autologous | B-Cell Non-Hodgkin Lymphoma – Relapse | Hematology | 2012 | Standard Therapy | Germany | 70 |
| 8449 | Apheresis | Autologous | Central Nervous System Non-Hodgkin Lymphoma | Hematology | 2012 | Standard Therapy | Germany | 54 |
| 8450 | Apheresis | Autologous | Cerebral Diffuse Large B-Cell Lymphoma-Relapse | Hematology | 2012 | Standard Therapy | Germany | 55 |
| 8451 | Apheresis | Autologous | Diffuse Large B-Cell Non-Hodgkin-Lymphoma | Hematology | 2012 | Standard Therapy | Germany | 54 |
| 8452 | Apheresis | Autologous | Extragonadal Germ Cell Tumor | Hematology | 2012 | Standard Therapy | Germany | 59 |
| 8453 | Apheresis | Autologous | Follicular Lymphoma | Hematology | 2012 | Standard Therapy | Germany | 54 |
| 8454 | Apheresis | Autologous | Follicular Lymphoma | Hematology | 2012 | Standard Therapy | Germany | 57 |
| 8455 | Apheresis | Autologous | Follicular Lymphoma-Relapse | Hematology | 2012 | Standard Therapy | Germany | 59 |
| 8456 | Apheresis | Autologous | Lymphoblastic B-Cell Non-Hodgkin-Lymphoma | Hematology | 2012 | Standard Therapy | Germany | 52 |
| 8457 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2012 | Standard Therapy | Germany | 61 |
| 8458 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2012 | Standard Therapy | Germany | 52 |
| 8459 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2012 | Standard Therapy | Germany | 57 |
| 8460 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2012 | Standard Therapy | Germany | 55 |
| 8461 | Apheresis | Autologous | Medulloblastoma | Hematology | 2012 | Standard Therapy | Germany | 42 |
| 8462 | Apheresis | Autologous | Morbus Hodgkin-Relapse | Hematology | 2012 | Standard Therapy | Germany | 27 |
| 8463 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2012 | Standard Therapy | Germany | 51 |
| 8464 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2012 | Standard Therapy | Germany | 60 |
| 8465 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2012 | Standard Therapy | Germany | 52 |
| 8466 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2012 | Standard Therapy | Germany | 71 |
| 8467 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2012 | Standard Therapy | Germany | 61 |
| 8468 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2012 | Standard Therapy | Germany | 53 |
| 8469 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2012 | Standard Therapy | Germany | 55 |
| 8470 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2012 | Standard Therapy | Germany | 70 |
| 8471 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2012 | Standard Therapy | Germany | 46 |
| 8472 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2012 | Standard Therapy | Germany | 64 |
| 8473 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2012 | Standard Therapy | Germany | 56 |
| 8474 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2012 | Standard Therapy | Germany | 68 |
| 8475 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2012 | Standard Therapy | Germany | 48 |
| 8476 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2012 | Standard Therapy | Germany | 59 |
| 8477 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2012 | Standard Therapy | Germany | 62 |
| 8478 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2012 | Standard Therapy | Germany | 72 |
| 8479 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2012 | Standard Therapy | Germany | 50 |
| 8480 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2012 | Standard Therapy | Germany | 60 |
| 8481 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2012 | Standard Therapy | Germany | 65 |
| 8482 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2012 | Standard Therapy | Germany | 67 |
| 8483 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2012 | Standard Therapy | Germany | 49 |
| 8484 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2012 | Standard Therapy | Germany | 69 |
| 8485 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2012 | Standard Therapy | Germany | 62 |
| 8486 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2012 | Standard Therapy | Germany | 57 |
| 8487 | Apheresis | Autologous | Non-Hodgkin-Lymphoma-Relapse | Hematology | 2012 | Standard Therapy | Germany | 62 |
| 8488 | Apheresis | Autologous | Non-Hodgkin-Lymphoma-Relapse | Hematology | 2012 | Standard Therapy | Germany | 57 |
| 8489 | Apheresis | Autologous | Non-Hodgkin-Lymphoma-Relapse | Hematology | 2012 | Standard Therapy | Germany | 44 |
| 8490 | Apheresis | Autologous | Non-Hodgkin-Lymphoma-Relapse | Hematology | 2012 | Standard Therapy | Germany | 43 |
| 8491 | Apheresis | Allogeneic | Osteomyelofibrosis | Hematology | 2012 | Standard Therapy | Germany | 61 |
| 8492 | Apheresis | Autologous | Plasmablastic Lymphoma | Hematology | 2012 | Standard Therapy | Germany | 54 |
| 8493 | Apheresis | Autologous | Plasmacytoma | Hematology | 2012 | Standard Therapy | Germany | 69 |
| 8494 | Apheresis | Autologous | Testicular Cancer Relapse | Hematology | 2012 | Standard Therapy | Germany | 36 |
| 8495 | Cord Tissue | Allogeneic – Unrelated | Acute Graft Versus Host Disease | Hematology | 2011 | Experimental Therapy | Poland | 17 |
| 8496 | Cord Blood | Allogeneic – Related | Acute Lymphoblastic Leukemia | Hematology | 2011 | Standard Therapy | Poland | 5 |
| 8497 | Cord Blood | Allogeneic – Related | Acute Lymphoblastic Leukemia | Hematology | 2011 | Standard Therapy | UK | 8 |
| 8498 | Cord Blood | Allogeneic – Related | Acute Myeloid Leukemia | Hematology | 2011 | Standard Therapy | Hungary | 2 |
| 8499 | Cord Blood | Autologous | Brain Damage | Neurology | 2011 | Experimental Therapy | Germany | 3 |
| 8500 | Cord Blood | Autologous | Brain Damage | Neurology | 2011 | Experimental Therapy | Germany | 7 |